Clinical Trial Update: Evaluation of 3TC or FTC Mono-therapy Compared to Continuing HAART as a Bridging Strategy [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating lamivudine (3TC) or emtricitabine (FTC) monotherapy as a bridging strategy versus continuing HAART in HIV infection; the study was term…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Emtricitabine (Emtricitabine)
• Lamivudine (lamivudine)

Snippet

Sponsor: International Maternal Pediatric Adolescent AIDS Clinical Trials Group | Conditions: HIV Disease | Phase 4 | Status: TERMINATED | Results posted: 2014-05-23